We connect science, innovation and impact.
Business
An integrated company
At Ferrer we believe that the true value of an innovation lies not only in discovering it, but in ensuring that it reaches the people who need it and contributes to improving their lives. That is why we integrate scientific, industrial and commercial capabilities that allow us to accompany the entire journey of an innovation, from research to access and support for patients. Because every scientific advance only reaches its true potential when it generates a real impact on people and society.
We promote scientific innovation
We direct our expertise and resources toward diseases where needs remain significant and therapeutic options remain limited. We focus on vascular and interstitial lung diseases and rare neurological diseases because we believe that no one should be left behind simply because their disease is rare, complex, or difficult to treat.
By focusing our efforts on specific therapeutic areas, we can develop deeper knowledge, drive innovation and contribute to improving the lives of people living with these diseases.
Our Capabilities
Research and development is just the beginning. For an innovation to reach the people who need it, it is necessary to have the appropriate capacities and infrastructures to develop it, produce it and guarantee its quality.
As an integrated company, we are able to connect research, active ingredient manufacturing and pharmaceutical production, helping scientific innovation to be transformed into therapeutic solutions efficiently, reliably and sustainably.
From our R+D facilities in Sant Cugat del Vallès, Spain. We promote projects focused on diseases with high unmet medical needs, combining scientific knowledge, experience in pharmaceutical development and an impact-oriented vision. We have teams specialized in formulation, analytical development and pharmaceutical development, supported by laboratories and infrastructures designed to accompany the entire process of developing new treatments. Our capabilities include the design and optimization of formulations, the development of analytical methods, the generation of scientific evidence and the scaling up of processes for future manufacturing.
The facilities include a GMP-certified pilot plant for the manufacture of investigational drugs and batches for clinical trials, as well as analytical development laboratories equipped with more than 100 specialized equipment. This infrastructure allows us to connect research, development and production within the same integrated environment. Our expertise spans the development of multiple dosage forms, including oral solid forms, liquids, granules, dispersible tablets, and complex formulations, applying advanced development and quality approaches from the earliest stages of the process.
The production of active ingredients is one of Ferrer's differential strengths as an integrated company. From our facilities in Sant Cugat del Vallès, Spain, we develop and manufacture active pharmaceutical ingredients, a strategic capability that allows us to participate in key stages of drug development and production.
Our facilities have synthesis laboratories equipped with advanced technology for the development of chemical processes and a GMP pilot plant that allows processes to be scaled up before industrial manufacturing. This integration between research, process development and production facilitates an efficient transfer of scientific knowledge to manufacturing.
With more than 18,000 m² of specialized facilities and extensive experience in pharmaceutical chemistry, we combine scientific knowledge, operational excellence and a strong commitment to quality, safety and sustainability. Our facilities operate under GMP standards and have international certifications and approvals that support our global activity.
Our industrial capacity allows us to turn scientific advances into medicines that can reach people with the maximum guarantees of quality, safety and reliability. As an integrated company, we closely connect research, pharmaceutical development, and manufacturing to ensure continuity throughout the entire process.
We have specialized facilities for the manufacture of different dosage forms, as well as the capabilities to produce both medicines for clinical trials and commercialized products. This combination gives us the flexibility to accompany the complete development cycle of a treatment, from the early stages to its arrival on the market.
Our industrial structure is based on close coordination between production centres, logistics and quality systems, helping to guarantee continuity of supply and the ability to respond to the needs of patients and healthcare systems around the world.
Quality is part of every stage of our business, from research and development to manufacturing, distribution and follow-up of treatments once they are available to patients. This is not an isolated role, but a shared responsibility that guides the way we work.
Our quality, quality control, validation and compliance teams work in coordination at all stages of the process to ensure that our products meet the highest regulatory and safety standards. This oversight covers both our active ingredient manufacturing operations and pharmaceutical production, clinical studies and collaboration with external partners.
Continuous improvement, preparation for international inspections, data integrity and the robustness of our quality systems all contribute to building trust between patients, healthcare professionals and regulatory authorities. Because we understand that operational excellence is essential for innovation to reach people with all the guarantees.
Working to expand access
We know that developing an innovation is only part of the challenge. That's why we collaborate with healthcare professionals, patient organisations, authorities and health systems to help more people benefit from scientific advances. Our goal is to translate the value generated by innovation into better outcomes for patients, caregivers and societies.
We listen to understand better
Behind each diagnosis there is a person, a family and a reality that goes far beyond the health field.
We work together with patients, caregivers, healthcare professionals and patient organizations to better understand unmet needs and move towards solutions that respond to the real challenges people face in their daily lives. Because we believe that listening is essential to innovate better.
We reach people all over the world
Our solutions are present in more than 100 countries thanks to a combination of direct presence and international collaborations. This network allows us to help more people access treatments and continue to build lasting relationships with patients, healthcare professionals and communities around the world.
From research to access, from manufacturing to patient accompaniment, we understand each stage as part of the same commitment. A commitment to people living with serious and debilitating illnesses. A commitment to science. And a commitment to the belief that the company can be a force for lasting positive impact. Because we believe that health, dignity, and opportunity are deeply connected.
Related news
-
Ferrer included in the ranking of the most ethical companies in the world in 2026
5 -
Ferrer reinforces its impact in 2024 with more social and environmental investment, B Corp leadership and advances in sustainability
5 -
We are the highest scoring pharmaceutical B Corp in the world
5 -
Ferrer is recognized as a leader in compliance with ethical and responsible corporate practices
5 -
Discover our 2023 Sustainability Report
5
